SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-309778
Filing Date
2020-12-04
Accepted
2020-12-03 20:26:59
Documents
1
Group Members
BETA ACQUISITION CORP.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d40475dsc13da.htm SC 13D/A 75054
  Complete submission text file 0001193125-20-309778.txt   76839
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79091 | Film No.: 201368323
SIC: 2834 Pharmaceutical Preparations

Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filed by) CIK: 0001593034 (see all company filings)

IRS No.: 680683755 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations